Combined expression pattern of satb family chromatin organizers as improved biomarker tool for cancer prognosis
AssigneeIndian Institute of Science Education and Research
InventorsSanjeev GALANDE, Rutika NAIK
Life of this patent
Estimating the term…
Loading patent…
AssigneeIndian Institute of Science Education and Research
InventorsSanjeev GALANDE, Rutika NAIK
Estimating the term…
The present invention provides an in-vitro process for profiling a combined expression pattern of SATB (special AT-rich sequence-binding protein-1) family chromatin organizers i.e. SATB-1 and SATB-2 as a biomarker tool for cancer prognosis to assess cancer aggressiveness and it progression in an array of cancer types. The combined expression pattern of SATB is established by the method of Kaplan Meier survival analysis of a dataset of patients from a plurality of cancer types. Further, the present invention provides a prognostic kit to evaluate the progression of cancer by using the combined expression pattern of SATB-1 and SATB-2 as a biomarker tool for cancer prognosis.
An in-vitro method for evaluating the progression and aggressiveness of cancer in a subject, characterized by evaluating the combined expression levels of SATB-1 and SATB-2 (Special AT-rich Sequence-Binding Protein) chromatin organizers which comprises;
A prognostic kit for evaluating the progression and aggressiveness of a cancer type in a subject diagnosed with cancer comprising;
Dependencies are inferred from the claim text.